 | • レポートコード：MRC2-11QY11526 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はCRISPR・Cas遺伝子のグローバル市場について調査・分析したレポートです。種類別（ベクターベースCas、DNAフリーのCas、細胞株エンジニアリング）市場規模、用途別（バイオテクノロジー・製薬会社、学術・政府研究所、委託研究機関（CRO））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別CRISPR・Cas遺伝子の競争状況、市場シェア ・世界のCRISPR・Cas遺伝子市場：種類別市場規模 2015年-2020年（ベクターベースCas、DNAフリーのCas、細胞株エンジニアリング） ・世界のCRISPR・Cas遺伝子市場：種類別市場規模予測 2021年-2026年（ベクターベースCas、DNAフリーのCas、細胞株エンジニアリング） ・世界のCRISPR・Cas遺伝子市場：用途別市場規模 2015年-2020年（バイオテクノロジー・製薬会社、学術・政府研究所、委託研究機関（CRO）） ・世界のCRISPR・Cas遺伝子市場：用途別市場規模予測 2021年-2026年（バイオテクノロジー・製薬会社、学術・政府研究所、委託研究機関（CRO）） ・北米のCRISPR・Cas遺伝子市場分析：米国、カナダ ・ヨーロッパのCRISPR・Cas遺伝子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのCRISPR・Cas遺伝子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のCRISPR・Cas遺伝子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのCRISPR・Cas遺伝子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CRISPR Therapeutics、AstraZeneca、Addgene、Caribou Biosciences, Inc.、Cellectis、Editas Medicine, Inc.、Egenesis、F. Hoffmann-La Roche Ltd.、Horizon Discovery Group Plc、Genscrip、Danaher Corporation、Intellia Therapeutics, Inc.、Lonza、Merck KGaA、New England BioLabs、Takara Bio, Inc.、Synthego、Mammoth Biosciences、Inscripta, Inc.、Cibus ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral (i.e. anti-phage) defense system of prokaryotes.
Cas9 (or “CRISPR-associated protein 9”) is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
Diagram of the CRISPR prokaryotic antiviral defense mechanism. The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages and provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA.
Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
Market Analysis and Insights: Global CRISPR & Cas Genes Market
The global CRISPR & Cas Genes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR & Cas Genes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR & Cas Genes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR & Cas Genes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR & Cas Genes market.
Global CRISPR & Cas Genes Scope and Market Size
CRISPR & Cas Genes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR & Cas Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Vector-based Cas
DNA-free Cas
Cell Line Engineering
Market segment by Application, split into
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations (CROs)
Based on regional and country-level analysis, the CRISPR & Cas Genes market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR & Cas Genes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
CRISPR Therapeutics
AstraZeneca
Addgene
Caribou Biosciences, Inc.
Cellectis
Editas Medicine, Inc.
Egenesis
F. Hoffmann-La Roche Ltd.
Horizon Discovery Group Plc
Genscrip
Danaher Corporation
Intellia Therapeutics, Inc.
Lonza
Merck KGaA
New England BioLabs
Takara Bio, Inc.
Synthego
Mammoth Biosciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas Genes Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Vector-based Cas
1.2.3 DNA-free Cas
1.2.4 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas Genes Market Share by Application: 2020 VS 2026
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academics and Government Research Institutes
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas Genes Market Perspective (2015-2026)
2.2 Global CRISPR & Cas Genes Growth Trends by Regions
2.2.1 CRISPR & Cas Genes Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR & Cas Genes Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR & Cas Genes Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas Genes Players by Market Size
3.1.1 Global Top CRISPR & Cas Genes Players by Revenue (2015-2020)
3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Players (2015-2020)
3.2 Global CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas Genes Revenue
3.4 Global CRISPR & Cas Genes Market Concentration Ratio
3.4.1 Global CRISPR & Cas Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas Genes Revenue in 2019
3.5 Key Players CRISPR & Cas Genes Area Served
3.6 Key Players CRISPR & Cas Genes Product Solution and Service
3.7 Date of Enter into CRISPR & Cas Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas Genes Breakdown Data by Type (2015-2026)
4.1 Global CRISPR & Cas Genes Historic Market Size by Type (2015-2020)
4.2 Global CRISPR & Cas Genes Forecasted Market Size by Type (2021-2026)
5 CRISPR & Cas Genes Breakdown Data by Application (2015-2026)
5.1 Global CRISPR & Cas Genes Historic Market Size by Application (2015-2020)
5.2 Global CRISPR & Cas Genes Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR & Cas Genes Market Size (2015-2026)
6.2 North America CRISPR & Cas Genes Market Size by Type (2015-2020)
6.3 North America CRISPR & Cas Genes Market Size by Application (2015-2020)
6.4 North America CRISPR & Cas Genes Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe CRISPR & Cas Genes Market Size (2015-2026)
7.2 Europe CRISPR & Cas Genes Market Size by Type (2015-2020)
7.3 Europe CRISPR & Cas Genes Market Size by Application (2015-2020)
7.4 Europe CRISPR & Cas Genes Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China CRISPR & Cas Genes Market Size (2015-2026)
8.2 China CRISPR & Cas Genes Market Size by Type (2015-2020)
8.3 China CRISPR & Cas Genes Market Size by Application (2015-2020)
8.4 China CRISPR & Cas Genes Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan CRISPR & Cas Genes Market Size (2015-2026)
9.2 Japan CRISPR & Cas Genes Market Size by Type (2015-2020)
9.3 Japan CRISPR & Cas Genes Market Size by Application (2015-2020)
9.4 Japan CRISPR & Cas Genes Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia CRISPR & Cas Genes Market Size (2015-2026)
10.2 Southeast Asia CRISPR & Cas Genes Market Size by Type (2015-2020)
10.3 Southeast Asia CRISPR & Cas Genes Market Size by Application (2015-2020)
10.4 Southeast Asia CRISPR & Cas Genes Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Introduction
11.1.4 CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2015-2020))
11.1.5 CRISPR Therapeutics Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca CRISPR & Cas Genes Introduction
11.2.4 AstraZeneca Revenue in CRISPR & Cas Genes Business (2015-2020)
11.2.5 AstraZeneca Recent Development
11.3 Addgene
11.3.1 Addgene Company Details
11.3.2 Addgene Business Overview
11.3.3 Addgene CRISPR & Cas Genes Introduction
11.3.4 Addgene Revenue in CRISPR & Cas Genes Business (2015-2020)
11.3.5 Addgene Recent Development
11.4 Caribou Biosciences, Inc.
11.4.1 Caribou Biosciences, Inc. Company Details
11.4.2 Caribou Biosciences, Inc. Business Overview
11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Introduction
11.4.4 Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.4.5 Caribou Biosciences, Inc. Recent Development
11.5 Cellectis
11.5.1 Cellectis Company Details
11.5.2 Cellectis Business Overview
11.5.3 Cellectis CRISPR & Cas Genes Introduction
11.5.4 Cellectis Revenue in CRISPR & Cas Genes Business (2015-2020)
11.5.5 Cellectis Recent Development
11.6 Editas Medicine, Inc.
11.6.1 Editas Medicine, Inc. Company Details
11.6.2 Editas Medicine, Inc. Business Overview
11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Introduction
11.6.4 Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.6.5 Editas Medicine, Inc. Recent Development
11.7 Egenesis
11.7.1 Egenesis Company Details
11.7.2 Egenesis Business Overview
11.7.3 Egenesis CRISPR & Cas Genes Introduction
11.7.4 Egenesis Revenue in CRISPR & Cas Genes Business (2015-2020)
11.7.5 Egenesis Recent Development
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2015-2020)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
11.9 Horizon Discovery Group Plc
11.9.1 Horizon Discovery Group Plc Company Details
11.9.2 Horizon Discovery Group Plc Business Overview
11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Introduction
11.9.4 Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2015-2020)
11.9.5 Horizon Discovery Group Plc Recent Development
11.10 Genscrip
11.10.1 Genscrip Company Details
11.10.2 Genscrip Business Overview
11.10.3 Genscrip CRISPR & Cas Genes Introduction
11.10.4 Genscrip Revenue in CRISPR & Cas Genes Business (2015-2020)
11.10.5 Genscrip Recent Development
11.11 Danaher Corporation
10.11.1 Danaher Corporation Company Details
10.11.2 Danaher Corporation Business Overview
10.11.3 Danaher Corporation CRISPR & Cas Genes Introduction
10.11.4 Danaher Corporation Revenue in CRISPR & Cas Genes Business (2015-2020)
10.11.5 Danaher Corporation Recent Development
11.12 Intellia Therapeutics, Inc.
10.12.1 Intellia Therapeutics, Inc. Company Details
10.12.2 Intellia Therapeutics, Inc. Business Overview
10.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Introduction
10.12.4 Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.12.5 Intellia Therapeutics, Inc. Recent Development
11.13 Lonza
10.13.1 Lonza Company Details
10.13.2 Lonza Business Overview
10.13.3 Lonza CRISPR & Cas Genes Introduction
10.13.4 Lonza Revenue in CRISPR & Cas Genes Business (2015-2020)
10.13.5 Lonza Recent Development
11.14 Merck KGaA
10.14.1 Merck KGaA Company Details
10.14.2 Merck KGaA Business Overview
10.14.3 Merck KGaA CRISPR & Cas Genes Introduction
10.14.4 Merck KGaA Revenue in CRISPR & Cas Genes Business (2015-2020)
10.14.5 Merck KGaA Recent Development
11.15 New England BioLabs
10.15.1 New England BioLabs Company Details
10.15.2 New England BioLabs Business Overview
10.15.3 New England BioLabs CRISPR & Cas Genes Introduction
10.15.4 New England BioLabs Revenue in CRISPR & Cas Genes Business (2015-2020)
10.15.5 New England BioLabs Recent Development
11.16 Takara Bio, Inc.
10.16.1 Takara Bio, Inc. Company Details
10.16.2 Takara Bio, Inc. Business Overview
10.16.3 Takara Bio, Inc. CRISPR & Cas Genes Introduction
10.16.4 Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.16.5 Takara Bio, Inc. Recent Development
11.17 Synthego
10.17.1 Synthego Company Details
10.17.2 Synthego Business Overview
10.17.3 Synthego CRISPR & Cas Genes Introduction
10.17.4 Synthego Revenue in CRISPR & Cas Genes Business (2015-2020)
10.17.5 Synthego Recent Development
11.18 Mammoth Biosciences
10.18.1 Mammoth Biosciences Company Details
10.18.2 Mammoth Biosciences Business Overview
10.18.3 Mammoth Biosciences CRISPR & Cas Genes Introduction
10.18.4 Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2015-2020)
10.18.5 Mammoth Biosciences Recent Development
11.19 Inscripta, Inc.
10.19.1 Inscripta, Inc. Company Details
10.19.2 Inscripta, Inc. Business Overview
10.19.3 Inscripta, Inc. CRISPR & Cas Genes Introduction
10.19.4 Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020)
10.19.5 Inscripta, Inc. Recent Development
11.20 Cibus
10.20.1 Cibus Company Details
10.20.2 Cibus Business Overview
10.20.3 Cibus CRISPR & Cas Genes Introduction
10.20.4 Cibus Revenue in CRISPR & Cas Genes Business (2015-2020)
10.20.5 Cibus Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global CRISPR & Cas Genes Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Vector-based Cas
Table 4. Key Players of DNA-free Cas
Table 5. Key Players of Cell Line Engineering
Table 6. Global CRISPR & Cas Genes Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global CRISPR & Cas Genes Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global CRISPR & Cas Genes Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global CRISPR & Cas Genes Market Share by Regions (2015-2020)
Table 10. Global CRISPR & Cas Genes Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global CRISPR & Cas Genes Market Share by Regions (2021-2026)
Table 12. CRISPR & Cas Genes Market Market Trends
Table 13. CRISPR & Cas Genes Market Drivers
Table 14. CRISPR & Cas Genes Market Challenges
Table 15. CRISPR & Cas Genes Market Restraints
Table 16. Global CRISPR & Cas Genes Revenue by Players (2015-2020) (US$ Million)
Table 17. Global CRISPR & Cas Genes Market Share by Players (2015-2020)
Table 18. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR & Cas Genes as of 2019)
Table 19. Global CRISPR & Cas Genes by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CRISPR & Cas Genes Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CRISPR & Cas Genes Market Size by Type (2015-2020) (US$ Million)
Table 24. Global CRISPR & Cas Genes Market Size Share by Type (2015-2020)
Table 25. Global CRISPR & Cas Genes Revenue Market Share by Type (2021-2026)
Table 26. Global CRISPR & Cas Genes Market Size Share by Application (2015-2020)
Table 27. Global CRISPR & Cas Genes Market Size by Application (2015-2020) (US$ Million)
Table 28. Global CRISPR & Cas Genes Market Size Share by Application (2021-2026)
Table 29. North America CRISPR & Cas Genes Market Size by Type (2015-2020) (US$ Million)
Table 30. North America CRISPR & Cas Genes Market Share by Type (2015-2020)
Table 31. North America CRISPR & Cas Genes Market Size by Application (2015-2020) (US$ Million)
Table 32. North America CRISPR & Cas Genes Market Share by Application (2015-2020)
Table 33. North America CRISPR & Cas Genes Market Size by Country (US$ Million) (2015-2020)
Table 34. North America CRISPR & Cas Genes Market Share by Country (2015-2020)
Table 35. Europe CRISPR & Cas Genes Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe CRISPR & Cas Genes Market Share by Type (2015-2020)
Table 37. Europe CRISPR & Cas Genes Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe CRISPR & Cas Genes Market Share by Application (2015-2020)
Table 39. Europe CRISPR & Cas Genes Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe CRISPR & Cas Genes Market Share by Country (2015-2020)
Table 41. China CRISPR & Cas Genes Market Size by Type (2015-2020) (US$ Million)
Table 42. China CRISPR & Cas Genes Market Share by Type (2015-2020)
Table 43. China CRISPR & Cas Genes Market Size by Application (2015-2020) (US$ Million)
Table 44. China CRISPR & Cas Genes Market Share by Application (2015-2020)
Table 45. China CRISPR & Cas Genes Market Size by Region (US$ Million) (2015-2020)
Table 46. China CRISPR & Cas Genes Market Share by Region (2015-2020)
Table 47. Japan CRISPR & Cas Genes Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan CRISPR & Cas Genes Market Share by Type (2015-2020)
Table 49. Japan CRISPR & Cas Genes Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan CRISPR & Cas Genes Market Share by Application (2015-2020)
Table 51. Japan CRISPR & Cas Genes Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan CRISPR & Cas Genes Market Share by Country (2015-2020)
Table 53. Southeast Asia CRISPR & Cas Genes Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia CRISPR & Cas Genes Market Share by Type (2015-2020)
Table 55. Southeast Asia CRISPR & Cas Genes Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia CRISPR & Cas Genes Market Share by Application (2015-2020)
Table 57. Southeast Asia CRISPR & Cas Genes Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia CRISPR & Cas Genes Market Share by Country (2015-2020)
Table 59. CRISPR Therapeutics Company Details
Table 60. CRISPR Therapeutics Business Overview
Table 61. CRISPR Therapeutics Product
Table 62. CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 63. CRISPR Therapeutics Recent Development
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Product
Table 67. AstraZeneca Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Addgene Company Details
Table 70. Addgene Business Overview
Table 71. Addgene Product
Table 72. Addgene Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 73. Addgene Recent Development
Table 74. Caribou Biosciences, Inc. Company Details
Table 75. Caribou Biosciences, Inc. Business Overview
Table 76. Caribou Biosciences, Inc. Product
Table 77. Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 78. Caribou Biosciences, Inc. Recent Development
Table 79. Cellectis Company Details
Table 80. Cellectis Business Overview
Table 81. Cellectis Product
Table 82. Cellectis Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 83. Cellectis Recent Development
Table 84. Editas Medicine, Inc. Company Details
Table 85. Editas Medicine, Inc. Business Overview
Table 86. Editas Medicine, Inc. Product
Table 87. Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 88. Editas Medicine, Inc. Recent Development
Table 89. Egenesis Company Details
Table 90. Egenesis Business Overview
Table 91. Egenesis Product
Table 92. Egenesis Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 93. Egenesis Recent Development
Table 94. F. Hoffmann-La Roche Ltd. Business Overview
Table 95. F. Hoffmann-La Roche Ltd. Product
Table 96. F. Hoffmann-La Roche Ltd. Company Details
Table 97. F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 98. F. Hoffmann-La Roche Ltd. Recent Development
Table 99. Horizon Discovery Group Plc Company Details
Table 100. Horizon Discovery Group Plc Business Overview
Table 101. Horizon Discovery Group Plc Product
Table 102. Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 103. Horizon Discovery Group Plc Recent Development
Table 104. Genscrip Company Details
Table 105. Genscrip Business Overview
Table 106. Genscrip Product
Table 107. Genscrip Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 108. Genscrip Recent Development
Table 109. Danaher Corporation Company Details
Table 110. Danaher Corporation Business Overview
Table 111. Danaher Corporation Product
Table 112. Danaher Corporation Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 113. Danaher Corporation Recent Development
Table 114. Intellia Therapeutics, Inc. Company Details
Table 115. Intellia Therapeutics, Inc. Business Overview
Table 116. Intellia Therapeutics, Inc. Product
Table 117. Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 118. Intellia Therapeutics, Inc. Recent Development
Table 119. Lonza Company Details
Table 120. Lonza Business Overview
Table 121. Lonza Product
Table 122. Lonza Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 123. Lonza Recent Development
Table 124. Merck KGaA Company Details
Table 125. Merck KGaA Business Overview
Table 126. Merck KGaA Product
Table 127. Merck KGaA Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 128. Merck KGaA Recent Development
Table 129. New England BioLabs Company Details
Table 130. New England BioLabs Business Overview
Table 131. New England BioLabs Product
Table 132. New England BioLabs Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 133. New England BioLabs Recent Development
Table 134. Takara Bio, Inc. Company Details
Table 135. Takara Bio, Inc. Business Overview
Table 136. Takara Bio, Inc. Product
Table 137. Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 138. Takara Bio, Inc. Recent Development
Table 139. Synthego Company Details
Table 140. Synthego Business Overview
Table 141. Synthego Product
Table 142. Synthego Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 143. Synthego Recent Development
Table 144. Mammoth Biosciences Company Details
Table 145. Mammoth Biosciences Business Overview
Table 146. Mammoth Biosciences Product
Table 147. Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 148. Mammoth Biosciences Recent Development
Table 149. Inscripta, Inc. Company Details
Table 150. Inscripta, Inc. Business Overview
Table 151. Inscripta, Inc. Product
Table 152. Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 153. Inscripta, Inc. Recent Development
Table 154. Cibus Company Details
Table 155. Cibus Business Overview
Table 156. Cibus Product
Table 157. Cibus Revenue in CRISPR & Cas Genes Business (2015-2020) (US$ Million)
Table 158. Cibus Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR & Cas Genes Market Share by Type: 2020 VS 2026
Figure 2. Vector-based Cas Features
Figure 3. DNA-free Cas Features
Figure 4. Cell Line Engineering Features
Figure 5. Global CRISPR & Cas Genes Market Share by Application: 2020 VS 2026
Figure 6. Biotechnology and Pharmaceutical Companies Case Studies
Figure 7. Academics and Government Research Institutes Case Studies
Figure 8. Contract Research Organizations (CROs) Case Studies
Figure 9. CRISPR & Cas Genes Report Years Considered
Figure 10. Global CRISPR & Cas Genes Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global CRISPR & Cas Genes Market Share by Regions: 2020 VS 2026
Figure 12. Global CRISPR & Cas Genes Market Share by Regions (2021-2026)
Figure 13. Global CRISPR & Cas Genes Market Share by Players in 2019
Figure 14. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR & Cas Genes as of 2019
Figure 15. The Top 10 and 5 Players Market Share by CRISPR & Cas Genes Revenue in 2019
Figure 16. North America CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa CRISPR & Cas Genes Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. CRISPR Therapeutics Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 44. AstraZeneca Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 45. Addgene Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 46. Caribou Biosciences, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 47. Cellectis Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 48. Editas Medicine, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 49. Egenesis Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 51. Horizon Discovery Group Plc Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 52. Genscrip Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 53. Danaher Corporation Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 54. Intellia Therapeutics, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 55. Lonza Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 56. Merck KGaA Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 57. New England BioLabs Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 58. Takara Bio, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 59. Synthego Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 60. Mammoth Biosciences Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 61. Inscripta, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 62. Cibus Revenue Growth Rate in CRISPR & Cas Genes Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
遺伝子編集の世界市場（～2026年） Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication th…- セルベースラベルフリーモニタリングの世界市場（～2026年） Cell signaling is a transmission of molecular signals between the cells. Cells often receive many signals from the surrounding cells to ensure an appropriate response. Classical biochemical assays are used to quantify the signaling responses between the cells. However, in some instances, due to comp…
- 細胞株開発サービスの世界市場（～2026年） Market Analysis and Insights: Global Cell Line Development Services Market The global Cell Line Development Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cell Line Development Services Scope and Market Size …
- 細胞株開発の世界市場（～2026年） The process of developing stable cell lines often starts with transfecting selected host cells, typically CHO or HEK 293 cells with desired plasmids. There is an increase in demand for the cell line development market owing to the increasing demand for monoclonal antibodies, rising vaccine productio…
- ラベルフリー検出（LFD）の世界市場（～2026年） LFD technology is used in the process of drug discovery. The main use of LFD technology is kinetics and analysis during drug discovery. LFD technology is widely used for end-point screening and specificity testing. Some of the benefits of LFD technology include faster turnaround time, real-time kine…